journal article·2009-10Open access

Biomimetic apatite-coated alginate/chitosan microparticles as osteogenic protein carriers

Min Lee, Weiming Li, Ronald K. Siu, Julie Whang, Xinli Zhang, Chia Soo, Kang Ting, Benjamin M. Wu

Biomaterials· Volume 30· Issue 30

Abstract

Bone morphogenetic proteins (BMPs) are currently approved for spinal fusion, tibial fracture repair, and maxillofacial bone regeneration. However, BMP pleiotropism, paradoxical activities on precursor cells, and unexpected side effects at local and ectopic sites may limit their usage. Thus, the need remains for alternative osteoinductive factors that provide more bone-specific activities with fewer adverse effects. Nell-1 [Nel-like molecule-1; Nel (a protein highly expressed in neural tissue encoding epidermal growth factor like domain)] is a novel osteogenic protein believed to specifically target cells committed to the osteogenic lineage. The objective of this project is to incorporate Nell-1 into a moldable putty carrier that can adapt to bony defects and deliver Nell-1 to the local microenvironment. We show here that moldability can be achieved by mixing hyaluronan hydrogel with two types of particles: demineralized bone powder for osteoconductivity, and biomimetic apatite-coated alginate/chitosan microparticles for controlled Nell-1 delivery. Besides enhancing overall osteoconductivity of the carrier, the biomimetic apatite coating also provides a more sustained release (approximately 15% cumulative release over 30 days) and greatly reduces the initial burst release that is observed with non-coated alginate/chitosan microparticles (approximately 40% release after 1 day). The efficacy of Nell-1 delivery from these carriers was evaluated in a rat spinal fusion model against Nell-free carriers as controls. At 4 weeks post-implantation, Nell-1 enhanced spinal fusion rates as assessed by manual palpation, radiographs, high-resolution micro-computerized tomography (microCT), and histology. This moldable putty carrier system appears to be a suitable carrier for promoting osteogenesis, and will be further evaluated in larger animal models over longer periods to follow the remodeling of the regenerated bone.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · TGF-β signaling in diseases · Heterotopic Ossification and Related Conditions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (48)

Show source-provided references
1. A comparative analysis of the microarchitecture of cortical membranous and cortical endochondral onlay bone grafts in the craniofacial skeleton10.1097/00006534-199907000-00020 ↗
2. Suitability of the iliac crest as a site for harvest of autogenous bone-grafts10.1597/1545-1569_1993_030_0579_sotica_2.3.co_2 ↗
3. Calvarial bone graft harvest: a new technique10.1067/mhn.2000.110541 ↗
4. Donor-site morbidity after harvesting rib and iliac bone10.1097/00006534-198406000-00014 ↗
5. Harvesting autogenous iliac bone-grafts – a review of complications and techniques10.1097/00007632-198912000-00009 ↗
6. Complications associated with the harvesting of cranial bone-grafts10.1097/00006534-199501000-00002 ↗
7. Complications of harvesting cranial bone grafts10.1097/00006534-199609000-00039 ↗
8. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery10.1038/sj.gt.3302298 ↗
9. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures – a prospective, controlled, randomized study of four hundred and fifty patients10.2106/00004623-200212000-00001 ↗
10. The family of bone morphogenetic proteins10.1046/j.1523-1755.2000.00081.x ↗
11. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats10.2106/00004623-200305000-00020 ↗
12. Recombinant human bone morphogenetic protein-7 in maxillary sinus floor elevation surgery in 3 patients compared to autogenous bone grafts – a clinical pilot study10.1034/j.1600-051x.2000.027009627.x ↗
13. Human NELL-1 expressed in unilateral coronal synostosis10.1359/jbmr.1999.14.1.80 ↗
14. Craniosynostosis in transgenic mice overexpressing Nell-110.1172/JCI15375 ↗
15. Involvement of epidermal growth factor-like domain of NELL proteins in the novel protein–protein interaction with protein kinase C10.1006/bbrc.1999.1753 ↗
16. Biochemical characterization and expression analysis of neural thrombospondin-1-like proteins NELL1 and NELL210.1006/bbrc.1999.1638 ↗
17. Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects10.1093/hmg/ddl053 ↗
18. Craniosynostosis-associated gene Nell-1 is regulated by Runx210.1359/jbmr.061012 ↗
19. Nell-1-induced bone regeneration in calvarial defects10.2353/ajpath.2006.051210 ↗
20. Chitosan: a versatile biopolymer for orthopaedic tissue-engineering10.1016/j.biomaterials.2005.03.016 ↗
21. Alginate in drug delivery systems10.1081/DDC-120003853 ↗
22. Development of a new drug carrier made from alginate10.1002/jps.2600820909 ↗
23. Pharmaceutical applications of chitosan10.1016/S1461-5347(98)00059-5 ↗
24. Novel hydrophilic chitosan–polyethylene oxide nanoparticles as protein carriers10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4 ↗
25. A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery10.1016/S0378-5173(00)00403-8 ↗
26. Calcium alginate gel: a biocompatible and mechanically stable polymer for endovascular embolization10.1002/1097-4636(200101)54:1<76::AID-JBM9>3.0.CO;2-V ↗
27. Chitosan–alginate microparticles as a protein carrier10.1081/DDC-100104314 ↗
28. The effect of pH on the structural evolution of accelerated biomimetic apatite10.1016/j.biomaterials.2003.12.037 ↗
29. In vitro response of MC3T3-E1 preosteoblasts within three-dimensional apatite-coated PLGA scaffolds10.1002/jbm.b.30261 ↗
30. The effect of biomimetic apatite structure on osteoblast viability, proliferation, and gene expression10.1016/j.biomaterials.2004.02.030 ↗
31. Alginate/chitosan particulate systems for sodium diclofenac release10.1016/S0378-5173(01)00915-2 ↗
32. Consequences of knocking out BMP signaling in the mouse10.1002/gene.10167 ↗
33. Transcriptional mechanisms in osteoblast differentiation and bone formation10.1016/S0168-9525(03)00176-8 ↗
34. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts10.1016/S0092-8674(00)80258-5 ↗
35. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa110.1210/edrv.21.4.0403 ↗
36. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein10.1038/sj.onc.1205937 ↗
37. Expression of human bone morphogenetic proteins-2 or proteins-4 in murine mesenchymal progenitor C3h10t1/2 cells induces differentiation into distinct mesenchymal cell lineages10.1089/dna.1993.12.871 ↗
38. Bone morphogenetic protein-2 converts the differentiation pathway of C2c12 myoblasts into the osteoblast lineage10.1083/jcb.127.6.1755 ↗
39. The osteoinductive properties of Nell-1 in a rat spinal fusion model10.1016/j.spinee.2006.04.020 ↗
40. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review10.1016/S0142-9612(00)00126-5 ↗
41. Ectopic osteogenesis and chondrogenesis of bone marrow stromal stem cells in alginate system10.1016/j.cellbi.2007.01.011 ↗
42. Chitosan–alginate hybrid scaffolds for bone tissue engineering10.1016/j.biomaterials.2004.09.062 ↗
43. Surface-mediated gene transfer from nanocomposites of controlled texture10.1038/nmat1179 ↗
44. Nanostructured calcium phosphates (NanoCaPs) for non-viral gene delivery: influence of the synthesis parameters on transfection efficiency10.1016/j.biomaterials.2006.10.026 ↗
45. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering10.1016/j.addr.2007.03.011 ↗
46. Hydroxyapatite particles as a controlled release carrier of protein10.1016/j.biomaterials.2003.10.081 ↗
47. Adsorption of bovine serum–albumin onto synthetic calcium hydroxyapatite – influence of particle texture10.1016/0927-7765(95)98210-E ↗
48. Influence of ionic strength and carbonate on the Ca–P coating formation from SBFx5 solution10.1016/S0142-9612(01)00318-0 ↗